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Abstract
An immunocompetent 51 year-old female presented to the Emergency Department (ED) with a
chief complaint of transient loss of consciousness and was found to have cryptococcal meningitis.
She complained of general fatigue and a 'cramping' sensation in her right arm for one week. The
physical exam was significant for the presence of a right homonymous hemianopsia and the absence
of fever or signs of meningismus. A computed tomography (CT) of the brain was interpreted as
showing an age-indeterminate infarct in the left parietal region. However, a magnetic resonance
imaging (MRI) of the brain showed multiple areas of meningeal enhancement. Cerebrospinal fluid
analysis revealed a positive cryptococcal antigen and 105 white blood cells. The patient was
successfully treated with Amphotericin B and fluconazole. While cryptococcal meningitis is typically
a disease of the immunocompromised, it can, as in this case, present in an immuncompetent host.
Introduction
Transient loss of consciousness is a common complaint
representing 3–5% of ED visits annually in the United
States [1]. The differential diagnosis for transient loss of
consciousness is broad and includes meningitis. In this
case the likelihood that this patient suffered from menin-
gitis was low given the fact that she was afebrile, immuno-
competent, and without meningismus. Cryptococcal
meningitis, caused by the encapsulated yeast Cryptococ-
cus neoformans, is known most notably as an opportun-
istic infection in patients with human immunodeficiency
virus (HIV) and other conditions associated with an
immunocompromised state (alcoholism, diabetes, malig-
nancy, etc.). Recently, reports of cryptococcal infections in
immunocompetent hosts have been described in the liter-
ature [2-6]. The initial clinical presentation of these
patients have included pulmonary infections, sepsis syn-
dromes, and subacute meningoencephalitis. To our
knowledge, this is the first reported case of cryptococcal
meningitis in an immunocompetent patient presenting to
the ED with transient loss of consciousness.
Case presentation
A 51-year-old woman presented to the ED with the chief
complaint of transient loss of consciousness and right arm
pain while washing dishes. She was unable to recall the
amount of time she lost consciousness but stated that she
was at her baseline mental status when her daughter
returned home from work that evening. In the ED, the
patient denied chest pain, palpitations, abdominal pain,
or vertigo prior to her inciting event. She stated that she
had noticed an increase in general fatigue and headaches
for two weeks, but denied fever, myalgias, or any sick con-
tacts. She acknowledged that her headaches felt like her
migraines except that they had been constant for one
week. The patient described her arm pain as an intermit-
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tent cramping sensation that had been present for less
than twenty-four hours. Her past medical history was sig-
nificant for migraine headaches, chronic hepatitis C, con-
gestive heart failure, chronic obstructive pulmonary
disease, and a recent diagnosis of a urinary tract infection.
Medications included ciprofloxacin, propranolol, furo-
semide, spironolactone, albuterol, trazodone, and esome-
prazole. Her social history was significant for a remote
history of intravenous drug use and daily alcohol use until
7 months prior to presentation. Family history was signif-
icant for coronary artery disease and diabetes. The patient
denied any medication allergies. Presenting ED vital signs
were a temperature of 98.0 degrees, blood pressure 117/
81 mm Hg, pulse 76 beats/min, respirations 18 breaths/
min, and oxygen saturation of 98% on room air.
The physical exam revealed a patient in no apparent dis-
tress that was alert and oriented to name, place and time.
She had equal and reactive pupils, a normal oropharyn-
geal exam, supple neck without pain on range of motion,
clear lung fields, a normal cardiac and abdominal exam,
and normal extremities. Her skin did not show any signs
of a rash or stigmata of chronic liver disease. Neurologic
testing revealed a right homonymous hemianopsia, nor-
mal strength, deep tendon reflexes, and sensation bilater-
ally. Her gait was steady and she had a normal cerebellar
exam.
A CT of the brain demonstrated an age-indeterminate inf-
arct in the left parietal region and multiple areas of new
small vessel ischemic disease. Laboratory evaluation
revealed a serum white blood cell count (WBC) of 8.9 ×
109 with 78% neutrophils, 16% lymphocytes, 4% mono-
cytes and 1% eosinophils, a hemoglobin of 13.8 gm/dl,
and platelets 88 k/cumm. While her basic electrolytes
were unremarkable, the liver function panel revealed a
total bilirubin of 3.5 mg/dL, alkaline phosphatase 100
units/L, SGOT (AST) 104 units/L, SGPT (ALT) 74 units/L,
and ammonia 15 mcmol/L.
Based on these data, Neurology consultation was
obtained. They admitted the patient with a presumptive
diagnosis of acute cerebrovascular accident (CVA) involv-
ing the occipital region. An MRI of the brain the next
morning revealed multiple areas of meningeal enhance-
ment without evidence of CVA. A lumbar puncture (LP)
was performed and the cerebrospinal fluid (CSF) revealed
105 white blood cells with 29% monocytes, 0 polymor-
phonuclear cells, and 71% lymphocytes, 0 red blood cells,
elevated protein at 176 mg/dL, low glucose at 21 mg/dL,
and the cryptococcal antigen returned positive with a titer
of 1:32. Human immunodeficiency virus tests were all
negative. The patient was subsequently started on Ampho-
tericin B.
The patient's hospital course was complicated by transient
acute renal failure due to Amphotericin B requiring a
medication change to liposomal Amphotericin and fluco-
nazole. The CSF culture remained negative for any growth
and the cryptococcal antigen titer decreased to 1:8 and 1:2
on two subsequent LP's. The patient was discharged on
hospital day 21 without neurologic sequalae and was
instructed to take fluconazole 400 milligrams once daily
for 24 weeks duration then 200 mg daily for life. Her cyp-
tococcal antigen became undetectable 4 weeks following
her hospital discharge.
Discussion
Cryptococcal meningitis is a common opportunistic
infection in acquired immunodeficiency syndrome
(AIDS); however, its prevalence among immunocompe-
tent hosts is not well established but may be increasing [2-
6]. Potential explanations for this increase include the suc-
cess of anti-retroviral therapy and a difference in virulence
among varieties of Cryptococcus neoformans serotypes,
namely var. neoformans, var. grubii, and var. gattii [6].
Cryptococcus neoformans var. gattii is believed to be the
most virulent [7].
The clinical course of cryptococcal meningitis is indolent
with a median time to diagnosis from symptom onset of
44 days with a range of 7 days to 1 year.[3] Transmission
is inhalational in the majority of cases [7]. Common pre-
senting symptoms include headache, fever, and malaise.
Classic meningitic findings, such as nuchal rigidity, are
absent in 75% of cases.[5] Visual changes have been
reported, such as the field defects seen in our patient, as
well as new onset seizure activity [8]. Cryptococcal men-
ingitis has also been shown to cause ischemic brain injury
[9].
Cryptococcal antigen detection in the CSF is 99% sensitive
when titers are 1:2048 and remains the most sensitive
confirmation test for establishing the diagnosis [7,10].
Computed tomography of the brain is normal in 50% of
proven cases; however, a focal neurological exam and
abnormalities on CT or MRI of the brain have both been
linked to a poorer prognosis [7]. Mortality rates for cryp-
tococcal meningitis in AIDS patients and immunocompe-
tent patients are estimated to be between 30% to 50% and
25 to 44%, respectively [2,5]. Recommended treatment
includes a 3 step treatment approach: induction (2 weeks
of amphotericin B 0.7–1 mg/kg/day plus flucytosine 100
mg/kg/day) followed by consolidation (8 weeks of fluco-
nazole 400 mg/day) and then maintenance (fluconazole
200 mg/day for life) [7].
The patient described in this case had a rare etiology of a
common ED complaint. Clues to the diagnosis in this case
included an atypical headache and fatigue for 2 weeksPublish with BioMed Central    and   every 
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(subacute), ischemic changes on head CT, a homony-
mous hemianopsia, and meningeal enhancement on the
initial MRI. The physicians' focus on a CVA as the etiology
in this particular patient could have resulted in a signifi-
cant delay in therapy and a poor outcome. Physicians
should be made aware that cryptococcal meningitis is
increasing among the immunocompetent population,
and it may present as subacute meningoencephalitis with-
out classic signs of meningismus. Precise prevalence fig-
ures are not known which may be due to under-reporting
secondary to the belief that cryptococcal meningitis is typ-
ically seen in the immunocompromised population.
Detection of cryptococcal meningitis in the immunocom-
petent host may improve if CSF cryptococcal antigen tests
were sent on cases of patients suspected of having menin-
gitis in the ED. This novel case is the first reported immu-
nocompetent patient that was found to have cryptococcal
meningitis after presenting to the ED with transient loss of
consciousness.
Conclusion
Clinicians should be informed that cryptococcal meningi-
tis can present in immunocompetent hosts and may
appear clinically dissimilar to traditional meningitis.
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